報價延遲最少15分鐘:2026/04/28 10:29 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
65.31 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.73/3.77
|
|
企業價值
2.04B
|
| 資產負債 |
|
每股賬面淨值
10.52
|
| 現金流量 |
|
現金流量率
0.02
|
| 損益表 |
|
收益
427.54M
|
|
每股收益
7.05
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, drivingimproved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services. |
